Laelia Benoit, MD, PhD
Child and adolescent psychiatrist; associate researcher, Center for Research in Epidemiology and Population Health (CESP) of the French NIH (Inserm), Paris-Saclay University, France; combined fellow at the Yale Child Study Center; Co-Director of QUALab, Qualitative and Mixed Methods Lab, Yale University, New Haven, CT.
Dr. Benoit has no financial relationships with companies related to this material.
Mark L. Ruffalo, MSW, DPsa
Editor-in-Chief, The Carlat Psychotherapy Report. Psychotherapist in private practice in Tampa, Florida. Assistant Professor of Psychiatry at the University of Central Florida College of Medicine and Adjunct Instructor of Psychiatry at Tufts University School of Medicine.
Dr. Ruffalo has no financial relationships with companies related to this material.
Keith A. Trujillo, PhD.
Emeritus Professor of Psychology, California State University, San Marcos, CA.
Dr. Trujillo has no financial relationships with companies related to this material.
Snehal Bhatt, MD.Chief, Addiction Psychiatry; Professor, Psychiatry and Behavioral Sciences, University of New Mexico, Albuquerque, NM.
Dr. Bhatt has no financial relationships with companies related to this material.
Katherine L. Dixon-Gordon, PhD.
Associate professor; Director of Clinical Training and Clinical Program Head, Psychological and Brain Sciences, University of Massachusetts, Amherst, MA.
Dr. Dixon-Gordon has no financial relationships with companies related to this material.
J. John Mann, MD.
Paul Janssen Professor of Translational Neuroscience in Psychiatry and Radiology; Director, Molecular Imaging and Neuropathology Division; Co-Director, Columbia Center for Prevention and Treatment of Depression, Columbia University/New York State Psychiatric Institute, New York, NY.
Dr. Mann receives royalties from the Research Foundation for Mental Hygiene for the commercial use of the Columbia-Suicide Severity Rating Scale and royalties from Columbia University for the Columbia Psychiatry Pathways app. Relevant financial relationships listed for the author have been mitigated.
Beth Frates, MD. Part-time Clinical Assistant Professor, Harvard Medical School Physical Medicine and Rehabilitation.
Dr. Frates reports she is on the boards of Jenny Craig, obVus Solutions, and Clearning.com. Dr. Aiken has reviewed this educational activity and has determined that there is no commercial bias as a result of this financial relationship.
Dilip V. Jeste, MD.
Director, Global Research Network on Social Determinants of Health and Exposomics; President-Elect, World Federation for Psychotherapy; Editor-in-Chief, International Psychogeriatrics; Past President, American Psychiatric Association; and coauthor of Wiser (Sounds True; 2020).
Dr. Jeste has no financial relationships with companies related to this material.
Faizi Ahmed MD. Affiliate Assistant Professor of Psychiatry and Behavioral Neurosciences at the University of South Florida; private practice at The Neuropsychiatry and TMS Group, Tampa, Florida.
Dr. Ahmed has no financial relationships with companies related to this material.
Amos Turner, MD.
Assistant professor of clinical psychiatry, Yale School of Medicine, New Haven, CT.
Dr. Turner has no financial relationships with companies related to this material.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
RSS
